uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
12.89
+0.24 (1.90%)
May 15, 2025, 1:38 PM - Market open
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
$96,656
Profits / Employee
-$1,041,029
Market Cap
705.46M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
QURE News
- 5 days ago - uniQure N.V. (QURE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewsWire
- 7 days ago - uniQure: A Buy For Their Lead In Huntington's Program, In Light Of PTC's Data - Seeking Alpha
- 9 days ago - uniQure to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 24 days ago - uniQure: Bullish On Near-Term Catalysts After Breakthrough Therapy Designation For AMT-130 - Seeking Alpha
- 26 days ago - uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting - Seeking Alpha
- 4 weeks ago - Why Is Gene Therapy Developer uniQure Stock Trading Higher On Thursday? - Benzinga
- 4 weeks ago - uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington's Disease - GlobeNewsWire